The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...

Pharmaceutical giant Pfizer and French vaccine maker Valneva reported positive topline results from their phase three study ...

$10.4 billion invested in internal research and development projects, and Approximately $8.8 billion invested in business development transactions, primarily reflecting the Metsera acquisition and the ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer, with a price target of $26.00.